ESC Highlights

flipper_slider

Editor's Choice

Tom van der Hulle discusses the key findings for the YEARS study, and the advantages and disadvantages of using computed tomography pulmonary angiography for diagnosis of pulmonary embolism. FILMED AT THE EUROPEAN...

ESC Highlights Videos

John Greenwood talks about the rationale behind the CE-MARC 2 trial and the efficacy and safety endpoints. FILMED AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC) ANNUAL MEETING, AUGUST 2016 WHAT IS THE RATIONALE BEHIND THE CE-MARC 2 TRIAL? 00:10 – At the current time we’re aware that invasive...
Tom van der Hulle discusses the key findings for the YEARS study, and the advantages and disadvantages of using computed tomography pulmonary angiography for diagnosis of pulmonary embolism. FILMED AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC) ANNUAL MEETING, AUGUST 2016 AT THE MEETING YOU ARE...
Marc Bonaca discusses the aims and key findings of the PEGASUS-TIMI 54 trial, and how they could be incorporated into clinical practice. FILMED AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC) ANNUAL MEETING, AUGUST 2016 WHAT WERE THE AIMS OF THE PEGASUS-TIMI 54 TRIAL? 00:10 – PEGASUS-TIMI 54 was...
Jean Luc Vachiery discusses the rationale behind combination therapies in the treatment of pulmonary arterial hypertension. FILMED AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC) ANNUAL MEETING, AUGUST 2016 WHAT FACTORS INFORM RISK STRATIFICATION IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION?...